Cavan Appoints Matthew Harvey CEO of BC Bud Depot to Advisory Board
2014年5月27日 - 9:00PM
Marketwired
Cavan Appoints Matthew Harvey CEO of BC Bud Depot to Advisory Board
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 27, 2014) -
CAVAN VENTURES INC. (TSX-VENTURE:CVN) ("Cavan" or the "Company") is
pleased to provide a corporate update in regards to the continuing
exploration of the potential of the Medical Marijuana and
Hemp/Cannabinoid industry.
Cavan Ventures Inc. previously announced (see news release dated
2014-03-25) the diversification of its growth plan into the Medical
Marijuana and Hemp industry. To accelerate this process, Matthew
Harvey has joined the Company as its newest member to the advisory
board.
Mr. Harvey has been a master grower and in the industry since
the mid 1990's with world-wide exposure since 2004. Mr. Harvey is
the Founder and CEO of BC Bud Depot ("BCBD"), a producer of
marijuana seeds. BCBD takes pride in developing its award-winning
THC and CBD cannabis strains. BCBD also collaborates with other
breeders and dispensaries (including Reeferman Seeds, T.H.Seeds and
DNA Genetics, and to European breeders like Soma Seeds and Delta-9
labs, and California's The Honey Spot), and offers over 50
proprietary medicinal strains to date with access to over 150
marijuana strains collaborated together with associated partners.
During Mr. Harvey's tenure, BCBD has received over 21 Cannabis Cup
awards, including 7 first place awards, 9 Top Strain awards, 6 top
3 strain awards and an induction in 2009 to the Seed Bank Hall of
Fame award. Additionally, BC Bud Depot has outreach to over 11
North American dispensaries and over 60 worldwide retail and web
stores which stock BCBD'S products. Most recently, Mr. Harvey has
steered BCBD towards a new developmental approach to medicinal
genetics, producing unique strains to be used for specific medical
ailments.
Peter P. Swistak, President/CEO of Cavan Ventures Inc., states,
"The depth and scope of Mr. Harvey's knowledge is unparalleled and
Cavan is very fortunate to have access to this knowledge as we
believe he is the best in his field with an extensive bio and
proven track record. He will add tremendous value, credibility and
unique knowledge to Cavan in its analysis of the Medical Marijuana
and Hemp/Cannabinoid industry, and potential opportunities in that
industry. We are excited to have Mr. Harvey available to us while
we conduct due-diligence in the Cannabinoid/Medicinal Marijuana
space."
At this time, no transactions are in place, nor is there any
assurance that a new project will be concluded in the future.
For more information visit the website at
www.cavanventuresinc.com.
ON BEHALF OF THE BOARD
Peter P. Swistak, President
Forward-Looking Statement: Certain statements in this
release are forward-looking statements, which reflect the
expectations of management regarding the Company's plans with
respect to its existing graphite interests, future financings, and
the analysis and investigation of the medical marijuana sphere.
Forward-looking statements consist of statements that are not
purely historical, including any statements regarding beliefs,
plans, expectations or intentions regarding the future and
statements concerning the anticipated drilling programs, future
financings, and the Company proceeding with any transactions in the
medical marijuana sphere. Such statements are subject to risks and
uncertainties that may cause actual results, performance or
developments to differ materially from those contained in the
statements. No assurance can be given that any of the events
anticipated by the forward-looking statements will occur or, if
they do occur, what benefits the Company will obtain from them. In
particular, the Company cautions that any financings or potential
transactions cannot be predicted with certainty, and there can be
no assurance at this time that all required or desirable approvals
and consents to affect future financings or proposed transactions
will be achieved at all. These forward-looking statements reflect
management's current views and are based on certain expectations
and assumptions which may prove to be incorrect. A number of risks
and uncertainties could cause our actual results to differ
materially from those expressed or implied by the forward-looking
statements, including factors beyond the Company's control. These
forward-looking statements are made as of the date of this news
release.
Neither the TSX Venture
Exchange nor its Regulation Services Provider (as that term is
defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this
release.
Cavan Ventures
Inc.604-683-3995888-945-4770604-683-3988www.cavanventuresinc.com
Cavan Ventures Inc. (TSXV:CVN)
過去 株価チャート
から 5 2024 まで 6 2024
Cavan Ventures Inc. (TSXV:CVN)
過去 株価チャート
から 6 2023 まで 6 2024